LIFR and hepatocellular carcinoma: A more recent report suggested that LIF receptor subunit alpha (LIFR) sensitizes HCC cells to sorafenib-induced ferroptosis through NF-κB inhibition and the resultant downregulation of iron-sequestering lipocalin 2 (LCN2) [47].